Opinions
The Weekly Buzzing Stocks by Billy Kawasaki
MoonLake Immunotherapeutics
MLTX-Q
TOP PICK
Oct 02, 2025
$7.360
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
Premium content
TOP PICK
Financial Highlights for MoonLake Immunotherapeutics in Q2 '25. Gross Profit stood at -740,000, marking a -96.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Cost of Revenue was 740,000, a 96.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations. Social media mentions are up 59.1% in the past 24h.
MoonLake Immunotherapeutics
Healthcare
Financial Highlights for MoonLake Immunotherapeutics in Q2 '25. Gross Profit stood at -740,000, marking a -96.3% change since the last quarter. Gross profit showcases the efficiency in production and sales processes. Cost of Revenue was 740,000, a 96.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations. Social media mentions are up 59.1% in the past 24h.